Efficacy of Education Versus Education Plus Prescribed Fluid Intake on Hydration Status in High School Athletes
Launched by PEPSICO GLOBAL R&D · Oct 18, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective education about hydration is compared to a more hands-on approach that includes specific instructions on how much fluid to drink for high school athletes. Researchers found that many athletes arrive at practice not fully hydrated, which could affect their performance and health. The goal of the study is to see if giving athletes set fluid intake goals helps them stay better hydrated than just educating them about the importance of drinking fluids.
To participate in this study, athletes must be between 13 and 19 years old, currently enrolled in the IMG sports program, and able to understand the study in English. They should not be smokers or have any health issues that could affect their ability to participate in sports. Participants can expect to learn more about hydration and receive guidance on fluid intake during their training. This study aims to help improve hydration practices in young athletes, which is crucial for their health and performance in sports.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Females and males between the ages of 13-19 years old
- • 2. Non-smoker
- • 3. Currently enrolled in the IMG sports program
- • 4. Able to give verbal and written informed consent for participation as well as obtain parental consent if \<18 years of age
- • 5. Must be fluent in English reading, writing, and speaking
- • 6. Parental permission
- Exclusion Criteria:
- • 1. Expulsion from school for any reason
- • 2. Leaving the IMG sports program
- • 3. Pregnant or planning to become pregnant
- • 4. Illness or injury that impacts sport participation or fluid balance
- • 5. Taking any medication that impacts fluid balance
- • 6. Participation in a clinical trial within past 30 days
- • 7. Participation in any PepsiCo trial within past 6 months
- • 8. Any condition the study investigator believes would interfere with eligibility following the study protocol, effect the study results, or put the subject at undue risk
About Pepsico Global R&D
PepsiCo Global R&D is a leading innovator in the food and beverage industry, dedicated to advancing the science of nutrition and product development. With a strong focus on health and wellness, the organization conducts rigorous clinical trials to explore the efficacy and safety of its products, aiming to enhance consumer experiences while promoting sustainable practices. Leveraging cutting-edge research methodologies and a multidisciplinary approach, PepsiCo Global R&D collaborates with academic institutions and healthcare professionals to drive evidence-based advancements in nutrition, ensuring that its offerings meet the evolving needs of consumers worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bradenton, Florida, United States
Patients applied
Trial Officials
Kris Osterberg, PhD, RD
Principal Investigator
PepsiCo R&D Life Sciences, Sports Science
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported